Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | GLP1R | P43220 | 3/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19732523 | 0.95 | SMN1; SMN2 (0.51) | SMN1; SMN2HPGDHTTL3MBTL1EPHX2 | |
| SCHEMBL21767237 | 0.93 | SMN1; SMN2 (0.45) | SMN1; SMN2HPGDHTTTSHRL3MBTL1 | |
| SCHEMBL20008742 | 0.92 | SMN1; SMN2 (0.48) | SMN1; SMN2HPGDHTTTSHRL3MBTL1 | |
| SCHEMBL20365824 | 0.91 | SMN1; SMN2 (0.46) | SMN1; SMN2HPGDHTTTSHRL3MBTL1 | |
| SCHEMBL4964608 | 0.90 | HPGD (0.45) | SMN1; SMN2HPGDHTTCNR1GLP1R | |
| SCHEMBL19732577 | 0.90 | SMN1; SMN2 (0.45) | SMN1; SMN2HPGDHTTTSHRL3MBTL1 | |
| SCHEMBL17773347 | 0.90 | SMN1; SMN2 (0.47) | SMN1; SMN2HPGDHTTTSHRL3MBTL1 | |
| SCHEMBL17885935 | 0.89 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDHTTL3MBTL1EPHX2 | |
| SCHEMBL19732579 | 0.89 | SMN1; SMN2 (0.46) | SMN1; SMN2HPGDHTTTSHRL3MBTL1 | |
| SCHEMBL17885923 | 0.88 | SMN1; SMN2 (0.43) | SMN1; SMN2HPGDHTTTSHRCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9296762-B2 | Complexing agents and corresponding lanthanide complexes | CISBIO BIOASSAYS (FR) | 2016-03-29 | — | — | US | disclosed |
| US-20140336373-A1 | NOVEL COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES | CISBIO BIOASSAYS (FR) | 2014-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140336373-A1 | NOVEL COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES | RCC1, RCC2, C1R | SMN1; SMN2 3739/4885HPGD 4808/4885HTT 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.